In this study, we investigated the predictive value of radiological semantic features and lung-RADS in pulmonary nodules malignancy risk at 3 screening rounds. We obtained 199 patients (139 nodule-positive controls and 60 incident lung cancers) from the National Lung Screening Trial. It was found that semantic features outperformed lung-RADS at baseline and were comparable to lung-RADS at subsequent scans. We find addition of semantic features to lung-RADS improves malignancy risk prediction. Rationale: Lung computed tomography (CT) Screening Reporting and Data System (lung-RADS) has standardized follow-up and management decisions in lung cancer screening. To date, little is known how lung-RADS classification compares with radiological semantic features in risk prediction and diagnostic discrimination. Objectives: To compare the performance of radiological semantic features and lung-RADS in predicting nodule malignancy in lung cancer screening. Methods: We used data and low-dose CT (LDCT) images from the National Lung Screening Trial (NLST). The training cohort contained 60 patients with screen-detected incident lung cancers who had a positive baseline screen (T0) that was not diagnosed and then was diagnosed at second follow-up (T2), and 139 nodule-positive controls who had 3 consecutive positive screens (T0 to T2) that were not diagnosed as lung cancer. The testing cohort included 40 patients with incident lung cancers that were diagnosed at first follow-up (T1) and 40 nodulepositive controls. Twenty-four semantic features were scored on a point scale from the LDCT images. Multivariable linear predictor model was built on the semantic features and the performances were compared with lung-RADS in 3 screening rounds. We also combined nonesize-based semantic features with lung-RADS to improve malignancy detection. Results: At T0, the average area under the receiver operating characteristic curve (AUROC) for border definition in risk prediction was 0.72. The average AUROC for contour at T1 in risk prediction and T2 in diagnostic discrimination was 0.82 and 0.88, respectively. By comparison, the average AUROC of lung-RADS at T0, T1 and T2 were 0.60, 0.76 and 0.87, respectively. The combined model of the semantic features and lung-RADS shows improvement with AUROCs of 0.74, 0.88 and 0.96 at T0, T1, and T2, respectively, achieved by adding border definition (at T0) or contour (at T1 and T2). Conclusion: We find semantic features defined by border definition and contour performed similar to lung-RADS at follow-up time point and outperformed lung-RADS at baseline. These semantics alongside of lung-RADS shows improved performance to detect malignancy.
Introduction
Lung cancer is the leading cause of cancer death in the United States and around the world. [1] [2] [3] The National Lung Screening Trial (NLST) demonstrated a 20% reduction in lung cancer mortality for participants screened with low-dose computed tomography (LDCT) compared with standard chest radiography. 4 However, high falsepositive rates and overdiagnosis are limitations of lung cancer screening using LDCT. This is evident in the NLST trial, which reports 96.4% of the positive detections were not cancerous. 4 The consequences of high false positives include increased use of medical resources, additional radiation exposure, complications arising from invasive diagnostic procedures, and patient anxiety. It becomes critical to develop reliable screening-based malignancy risk predictor beyond size measurements.
In the NLST, screening criterion was based on nodule size; any noncalcified nodule measuring at least 4 mm in any diameter was considered as positive. Less commonly, other abnormalities were also considered a positive screen, such as adenopathy or pleural effusion. Subsequent studies have proposed that raising the threshold to 5 to 9 mm would substantially reduce false-positive rates at the expense of a few missed or delayed lung cancer cases. [5] [6] [7] There are a few diagnostic models [8] [9] [10] [11] [12] that have proposed the inclusion of additional image features beyond size. However, assessment has historically been restricted to features of nodules at 1 time point. Recently, the American College of Radiology (ACR) proposed lung computed tomography (CT) Screening Reporting and Data system (Lung-RADS) for standardizing screening CT interpretations and facilitating outcome monitoring, 13 which combines nodule attenuation and nodule size (baseline scan) or size changes (follow-up scan) to provide a risk assessment. Nodules are categorized into 4 risk levels; level 3 or higher was usually considered positive. The nodule attenuation is interlaced with the size measurement to provide the positive risk; an average diameter of 20 mm is allowed for ground-glass nodules, and 6-mm average diameter for solid nodules and 6-mm total diameter for part-solid nodules. Previous studies using lung-RADS 14, 15 observed a reduction of false-positive rate using their risk scores compared with the size criteria used by the NLST. One of the studies 14 assessed performance both at baseline and subsequent scans for the entire LDCT arm, but the problem was that individual nodules were not tracked over time. Also, the malignant nodule was not necessarily the largest one. In this analysis, both baseline and 2 follow-up LDCT scans were extracted from subsets of participants in the NLST, and images were reviewed to ensure that the nodules analyzed were matched across all 3 rounds of screening. A systematic radiological scoring sheet (semantics), which included nodule size, shape, margin, density, internal features, external features, and associate findings, was developed. Our group has been developing quantitative radiological semantics and relating them to clinical outcome. 16, 17 These features were proven to be reproducible and consistent among readers and were found to be prognostic. Recently, these semantics have been shown to be prognosticate recurrence-related survival after stereotactic body radiotherapy 18 in lung cancers. The goal of our analysis was to find reliable semantic descriptors that would discriminate malignancy at diagnosis and provide risk assessment both at diagnosis and early screening time instances. The performance was compared with lung-RADS and further, we show using 2 semantic features (contour and border definition) along with lung-RADS improves malignancy prediction.
Patients and Methods

NLST Study Population
The NLST dataset was obtained after executing the data transfer agreement between the National Cancer Institute and Moffitt Cancer Center. The images and clinical data were downloaded through The Cancer Imaging Archive and Cancer Data Access System portal. 19 The institutional review board at University of South Florida approved the retrospective analysis of publicly available data.
The detailed study design of the NLST has been previously described. 4 Briefly, a total of 53,454 individuals (between 55 and 74 years of age) with high risk of lung cancer at the time of randomization were enrolled from 2002 through 2004 at 33 US medical centers. The participants were randomly assigned between the LDCT and the radiography arm; the enrollees were asked to undergo a baseline (T0) and 2 annual follow-up screenings (T1 and T2). Participants with a lung cancer confirmed diagnosis would not be offered subsequent screening tests. All screening examinations were performed in accordance with a standard protocol.
In this study, we formed training and test sets that consisted of patients with incident lung cancer and nodule-positive controls. Patients with incident lung cancer had a baseline positive screen that was not determined to be lung cancer (ie, an indeterminate pulmonary nodule), but in the follow-up scans was diagnosed with an incidence of lung cancer at first (approximately 12 months or T1) or second (about 24 months or T2) screening. In our training cohort, 92 patients had positive nodules not related to lung cancer diagnosis at baseline (T0) and first follow-up (T1), but confirmed to be cancer at the second follow-up (T2). In the test set, there were 104 patients with lung cancer who had a baseline (T0) scan and confirmed to be cancer at the first follow-up (T1). In both training and testing sets, nodule-positive controls had 3 consecutive positive screens (T0 to T2) that were not diagnosed as lung cancer. The nodule-positive controls were frequency matched to the lung cancer cases on age, sex, race, smoking status, and pack-years smoked. The schema of the study is shown in Figure 1 . The patient IDs (PIDs) are listed in Supplemental Table 1 in the online version.
The lobe of cancerous nodule was provided by the NLST, whereas the location of nodule-positive controls was not available. The patient scans were reviewed by the study radiologists (J.Q. and Y.L.), who reached an agreement based on consensus assessment of the nodules that could be used for the analysis. In our initial patient list, 77 cases were excluded because of 1 or more of the following reasons: nonavailability of images, the location of tumor was unknown, nodules could not be identified, or multiple nodules that had malignant characteristics. In some participants, nodules were too small to be evaluated especially at baseline. In this process, there were 199 cases (60 incident lung cancer and 139 nodule-positive controls) converged for the training cohort. The study radiologist (J.Q.) reviewed the cancer cohort to locate and connect the nodules across the screening time points. An additional 80 patients were randomly chosen as a testing cohort, which had 40 patients with incident lung cancer and 40 nodule-positive controls. Because of the unavailability of prior scans, our test cohort had 1 prior scan with smaller size compared with the training set. To avoid sampling biases, the case and control samples were matched in the test cohort.
LDCT Image Analysis
LDCT images were displayed using both mediastinal (width 350 HU, level 40 HU) and lung (width 1500 HU, level À600 HU) window settings. In this study, we identified 24 radiological image traits (or semantics) to characterize the pulmonary nodules. These semantics can be broadly classified into 8 categories: (1) location, (2) size, (3) shape, (4) margin, (5) density, (6) internal features, (7) external features, and (8) associated findings (see Supplemental Table 2 in the online version). Each of these semantic features was systematically scored on a point scale (up to 5) by the study radiologist (Q.L.). Lung-RADS scores were independently evaluated in each time point according to the ACR 2014 guidelines. 13 There are certain biases between radiologists based on their individual expertise, so we evaluated the reproducibility of semantics scores between 2 radiologists. In this substudy, we randomly selected 40 patients (20 lung cancer, 20 nodule-positive controls) from the NLST trial and asked a second radiologist (Y.L.) to score the semantics. We provided a scoring sheet with radiological trait levels, along with details of the nodule being scored, which included slice number and anatomic location. The clinical diagnoses of the lung nodules were withheld during the semantic scoring period of the study. We then computed the dependency between semantic features and removed features that were highly correlated. The dependency was measured by computing the Pearson correlation (r) between all pairs of semantic features. We removed long axis diameter and thickened adjacent bronchovascular bundles due to high association with other features (r > 0.8). In addition, distribution and calcification were excluded because most of the nodules were peripheral and noncalcified in the study. This process resulted in 20 features that were used for predictor analysis.
Statistical Analysis
We used linear classifier to build a model based on semantic features and relate them to the cancer status. We exhaustively searched for the best pair of features to build the classifier model. The error of classifier was estimated using a fivefold holdout crossvalidation method, randomly repeated a large number of times (n ¼ 200). We report the average statistics across the repeats. 24, 25 For each discriminant feature pair, average area under the receiver operating characteristic curve (AUROC) and 95% confidence interval (CI) were computed. The top discriminating features were ordered based on the Youden J Index. 26 The sensitivity, specificity, average AUROC, and 95% CI were also calculated for lung-RADS (scale 3 or above called positive). The discriminatory analysis was repeated independently at each of the time points. The performance of the classifiers was validated on the test cohort. The best performing semantic feature was then used to develop the combined models with lung-RADS.
Results
The demographic and clinical covariates of the training and test sets are provided in Table 1 . Most patients with lung cancer were stage I (at training/testing: 76.6%/72.5% of the samples) cancers 
Performance of Lung-RADS
Lung-RADS is a clinically reliable tool and its performance is especially accurate when a prior scan is available. The performance deteriorates at baseline screen when no priors are available. In our study, at the time of cancer diagnosis with 2 prior scans available (T2), the AUROC of lung-RADSebased predictor was 0.87, with the sensitivity ranging from 0.77 to 0.85 and specificity from 0.95 to 0.97. At the prior time point (T1), the ability of lung-RADS in predicting cancer was a little lower, the AUROC was 0.76, sensitivity and specificity were 0.54 to 0.62 and 0.95 to 0.97, respectively. At baseline screening (T0), the lung-RADS predictor was the lowest with AUROC of 0.60 and the sensitivity was in the range of 0.40 to 0.47, and specificity was 0.75 to 0.79. Detailed reporting is presented in Table 2 .
Performance of Semantic Features in NLST
We found 9 semantic features with high level of reproducibility among the readers (kappa > 0.8). The features included vessel attachment, attenuation, air bronchogram, fissure attachment, pleural 
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Clinical Lung Cancer March 2018 -151 attachment, pleural retraction, bubble-like lucency, thickened adjacent bronchovascular bundles, and nodules in the primary tumor lobe. Seven other semantic features showed substantial agreement (kappa > 0.6), which included contour, border definition, concavity, lymphadenopathy, spiculation, nodules in nontumor lobes, and focal fibrosis. Three semantic features showed moderate agreement (kappa > 0.4), which included focal emphysema, vascular convergence, and lobulation. The ICCs for long and short axial diameter were 0.94 (95% CI, 0.89-0.97) and 0.96 (95% CI, 0.83-0.99), respectively. Detailed information is reported in Table 3 . We also performed a substudy to evaluate the influence of semantic predictor variability between 2 radiologists on the outcome prediction. The results 17 are reported in Supplemental Table 3 in the online version.
Comparing the performance of the semantic predictor among the 3 screening rounds (T0, T1, and T2) showed a steady improvement of sensitivity of the predictors with screening interval. The sensitivity of the predictor at T0 was in the range of 0.5 to 0.6, whereas at T1 it was approximately 0.6 to 0.7, and at T2 it improved to approximately 0.8. The specificity had small changes across different time points, which was in the range of 0.8 to 0.9.
We found semantics defined by contour and border definition to be the individual semantic features that were predictive of malignancy in all 3 screening rounds ( Figure 2 ). The semantics defined by border definition performed best at T0 (AUROC: 0.72), and contour performed well at both the time points, namely at T1 (AUROC: 0.82) and T2 (AUROC: 0.88).
We also found that vessel attachment when combined with other features shows predictive performance in all 3 screening time points. For example, when it was combined with contour and focal Semantic Features Improve Lung-RADS Performance in NLST emphysema, it was predictive of malignancy both at T1 and T2. When combined with border definition and attenuation, it was predictive at T0. Similarly, location was a predictive feature at T1 and T2, but performs well when combined with contour. We also found at T0, focal fibrosis was a predictive feature, when combined with border definition. The combination of short axial diameter, contour, border definition, and attenuation showed the highest AUROC at T0 (0.74).
At T1 (Table 2) , it was observed that location, contour, attenuation, and focal fibrosis was the best predictor (AUROC: 0.90). At diagnostic time T2, the 4-features combination, including location, contour, short axial diameter, and focal emphysema, achieved AUROC of 0.95 (training).
There is minimal difference in terms of AUROCs between semantic features and lung-RADS in predicting nodule malignancy at the time of diagnosis (at T2) but certainly semantic predictors show improved sensitivity. The semantic features had higher AUROC value before diagnostic screening time points, such as T1 and T0 compared with lung-RADS. When lung-RADS was combined with the top semantic feature, border definition (for T0) or contour (for T1 and T2), the combined features show an increase of 9.1% to 14.3% in the AUROC compared with lung-RADS (see Figure 3) . The actual AUROC comparisons between semantics and lung-RADS at 3 screening times T0, T1, and T2 were 0.74 versus 0.60, 0.88 versus 0.76, and 0.96 versus 0.87, respectively, and these AUROC differences were statistically significant (P < .05). 
Discussion
Using data and LDCT images from the NLST, we compared the performance of radiological semantic features and lung-RADS to discriminate between lung cancer cases and nodule-positive controls. The performance of the semantic features was comparable to lung-RADS independently at 3 screening time intervals and we show utility of using semantics to improve diagnosis. In this study, we converged on 2 nonesize-based semantic predictors defined by contour and border definition as individual malignancy predictors. These semantic features when combined with lung-RADS improve prediction ability.
Performance of Lung-RADS
The lung-RADS worked well in discriminating malignant nodules when a previous scan was available, although the performance diminishes when no priors are available, especially at baseline scan. The reason is that nodule size was too small to be defined as malignant at baseline. Meanwhile, it should be noted that lung-RADS relies on the nodule growth when a prior scan is available, and the risk assessment is based on actual nodule size at baseline scan. To illustrate the difference, we tried to reclassify the lung-RADS category at T2 using the actual size, ignoring prior scan. The falsepositive for such a method increased approximately 20% (from 3.6% to 25.89%). This indicates utility of using nodule growthebased risk assessment compared with actual size categorization in screening setting.
The study from Pinsky et al 14 used lung-RADS in NLST data; the sensitivity and specificity after baseline were similar to our findings, but our baseline sensitivity was lower. The discrepancy may be attributed to the following. First, the sample size is different. Pinsky et al 14 used all the participants in the NLST (LDCT cohort), whereas in our study we used subsets of participants in the NLST and divided them into training and test cohorts. Also, patients were manually curated and nodules were matched across time intervals for all 3 (2 for test cohort) time points. Importantly, the ratios of malignant and positive controls were significantly different. In our analysis, the cancer and noncancer cases were matched at the ratio of 1:2, whereas for the study of Pinsky et al, 14 the ratio was nearly 1:90 (at baseline), as they considered all the LDCT patients. Additionally, at baseline, we chose the nodule that was confirmed to be cancer at T2 even though larger nodules may coexist, and it may result that some of the nodules at T0 were rather small ( Figure 4 ). There were 24 patients (40%) with nodules smaller than 6 mm at T0.
Semantic Featureebased Malignancy Predictor
We found contour and border definition are the top nonesizebased features that are predictive of malignancy. These features have been used in prior studies [27] [28] [29] [30] [31] and have shown to be related to malignancy. It has been reported that nodule growth was related to shape characteristics, such as contour, morphology, border, or margin. 27 It is hypothesized that cancerous lung nodules would become more irregular over time. 30 van't Westeinde et al 28 suggested that contour (shape) and border should be first considered followed by nodule location and nodule growth. Our analysis provides justification to include these 2 features to improve predictive power of malignancy. We justify our findings by adding these semantics to lung-RADS and show an improved predictive performance.
There are a few more semantic features that show promise as biomarkers. Vessel invasion has shown to be a poor prognostic factor and is correlated with lung cancer recurrence. [32] [33] [34] It has been demonstrated that during the early stages of tumor growth, angiogenesis is required to permit tumor expansion. 35 Nodules with vessel attachment may be more susceptible to get vessels involved and develop progression. Nodule location was another important prognostic indicator of malignancy 9 and has been shown in a few studies. 30 Cancerous nodules more often seem to be related to upper lobes; in our study, occurrence was approximately 61.7% (n ¼ 37). In comparison, 40.3% (n ¼ 56) nodules in noncancer cases had nodules located in the upper lobe. Previously it has been shown that even early signs of emphysema and fibrosis are associated with lung cancer, 36 and the prevalence of lung cancer increased among those who had CT evidence of emphysema. 37 In our study, malignant nodules tended to have severe regional emphysema and fibrosis. We strongly believe that semantic descriptors are common features that radiologists use in daily practice, following semantic-based scoring approaches, and forming a predictive risk score like the lung-RADS would improve patient treatment.
Limitations
This study was based on retrospective analysis of patient data and the usable sample size was relatively small. Second, only 1 prior scan was available for the incident lung cancer group in testing cohort, which allowed proper comparison at 2 of the 3 screening time points (diagnosis and baseline scan). Third, the semantic scoring may have some biases among readers, although we have taken effort to reduce this by creating pictorial examples.
Conclusion
We have shown radiological-based discriminant feature predictors are comparable to the performance of lung-RADS in predicting malignancy. The results show lung-RADS are good malignancy predictors, especially when prior screening scans are available. Further, the semantic features (contour and border definition) when added to lung-RADS improves the predictive performance. We believe scoring semantics along with lung-RADS would improve the future of cancer risk assessment.
Clinical Practice Points
Screening for lung cancer with LDCT is associated with a significant reduction in lung cancererelated mortality. Despite the clinical benefit of this modality, a high false-positive rate is a substantial limitation. In this study, we examined the performance of quantitative "semantics" with lung-RADS to improve malignancy prediction. Semantic features outperformed lung-RADS for predicting subsequent occurrence of cancer at baseline scans, and the performance was comparable at subsequent scans. The performance of lung-RADS in assessing screening lung nodules can be improved by incorporating additional semantic features. Abbreviation: AUROC ¼ area under the receiver operating characteristic curve.
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